142 related articles for article (PubMed ID: 38830665)
1. Efficacy of denosumab treatment for lung metastasis secondary to proximal humerus chondroblastoma.
Samargandi R; Bernard M; Miquelestorena-Standley E; Nail LRL
Saudi Med J; 2024 Jun; 45(6):633-638. PubMed ID: 38830665
[TBL] [Abstract][Full Text] [Related]
2. Chondroblastoma's Lung Metastases Treated with Denosumab in Pediatric Patient.
Focaccia M; Gambarotti M; Hakim R; Paioli A; Cesari M; Spazzoli B; Spinnato P; Donati D; Rocca M; Longhi A
Cancer Res Treat; 2021 Jan; 53(1):279-282. PubMed ID: 32777878
[TBL] [Abstract][Full Text] [Related]
3. Treatment of Chondroblastoma with Denosumab: A Case Report with a Correlative Analysis of Effect on the RANK Signaling Pathway.
Visgauss JD; Lazarides A; Dickson B; Cardona D; Sheth M; DeWitt SB; Somarelli JA; Eward WC
JBJS Case Connect; 2021 May; 11(2):. PubMed ID: 33999872
[TBL] [Abstract][Full Text] [Related]
4. Response to Denosumab in 2 Children With Recurrent Giant Cell Tumor of the Bone With Pulmonary Metastasis.
Reddy K; Ramirez L; Kukreja K; Venkatramani R
J Pediatr Hematol Oncol; 2021 Mar; 43(2):e215-e218. PubMed ID: 31714440
[TBL] [Abstract][Full Text] [Related]
5. Chondroblastoma Expresses RANKL by RNA In Situ Hybridization and May Respond to Denosumab Therapy.
Suster DI; Kurzawa P; Neyaz A; Jarzembowski JA; Lozano-Calderon S; Raskin K; Schwab J; Choy E; Chebib I; Deshpande V
Am J Surg Pathol; 2020 Dec; 44(12):1581-1590. PubMed ID: 32826531
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic Potential of Denosumab in Patients With Lung Cancer: Beyond Prevention of Skeletal Complications.
De Castro J; García R; Garrido P; Isla D; Massuti B; Blanca B; Vázquez J
Clin Lung Cancer; 2015 Nov; 16(6):431-46. PubMed ID: 26264596
[TBL] [Abstract][Full Text] [Related]
7. What Happens to the Articular Surface After Curettage for Epiphyseal Chondroblastoma? A Report on Functional Results, Arthritis, and Arthroplasty.
Farfalli GL; Slullitel PA; Muscolo DL; Ayerza MA; Aponte-Tinao LA
Clin Orthop Relat Res; 2017 Mar; 475(3):760-766. PubMed ID: 26831477
[TBL] [Abstract][Full Text] [Related]
8. Which Bone-Modifying Agent is Associated with Better Outcomes in Patients with Skeletal Metastases from Lung Cancer? A Systematic Review and Network Meta-analysis.
Bozzo A; Deng J; Abbas U; Bhasin R; Deodat M; Wariach S; Sanger S; Axelrod D; Masrouha K; Turcotte R; Wilson D; Ghert M
Clin Orthop Relat Res; 2021 Sep; 479(9):2047-2057. PubMed ID: 33835092
[TBL] [Abstract][Full Text] [Related]
9. Denosumab does not decrease the risk of lung metastases from bone giant cell tumour.
Tsukamoto S; Mavrogenis AF; Leone G; Righi A; Akahane M; Tanzi P; Kido A; Honoki K; Tanaka Y; Donati DM; Errani C
Int Orthop; 2019 Feb; 43(2):483-489. PubMed ID: 30099641
[TBL] [Abstract][Full Text] [Related]
10. Overall survival improvement in patients with lung cancer and bone metastases treated with denosumab versus zoledronic acid: subgroup analysis from a randomized phase 3 study.
Scagliotti GV; Hirsh V; Siena S; Henry DH; Woll PJ; Manegold C; Solal-Celigny P; Rodriguez G; Krzakowski M; Mehta ND; Lipton L; García-Sáenz JA; Pereira JR; Prabhash K; Ciuleanu TE; Kanarev V; Wang H; Balakumaran A; Jacobs I
J Thorac Oncol; 2012 Dec; 7(12):1823-1829. PubMed ID: 23154554
[TBL] [Abstract][Full Text] [Related]
11. Risks and benefits of combining denosumab and surgery in giant cell tumor of bone-a case series.
Müller DA; Beltrami G; Scoccianti G; Campanacci DA; Franchi A; Capanna R
World J Surg Oncol; 2016 Nov; 14(1):281. PubMed ID: 27809843
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of denosumab in joint preservation for patients with giant cell tumour of the bone.
Traub F; Singh J; Dickson BC; Leung S; Mohankumar R; Blackstein ME; Razak AR; Griffin AM; Ferguson PC; Wunder JS
Eur J Cancer; 2016 May; 59():1-12. PubMed ID: 26990281
[TBL] [Abstract][Full Text] [Related]
13. Chondroblastoma with pulmonary metastasis in a patient presenting with spontaneous bilateral pneumothorax: Report of a case.
Tamura M; Oda M; Matsumoto I; Sawada-Kitamura S; Watanabe G
Surg Today; 2011 Oct; 41(10):1439-41. PubMed ID: 21922374
[TBL] [Abstract][Full Text] [Related]
14. A case of pelvic giant cell tumor of bone, complete remission with denosumab: long duration of response.
Bilgetekin I; Mammadkhanli O; Basal FB; Kandemir O; Canbay S; Oksuzoglu B
Anticancer Drugs; 2020 Jun; 31(5):533-535. PubMed ID: 31743134
[TBL] [Abstract][Full Text] [Related]
15. Response evaluation of giant-cell tumor of bone treated by denosumab: Histogram and texture analysis of CT images.
Yi J; Lee YH; Kim SK; Kim SH; Song HT; Shin KH; Suh JS
J Orthop Sci; 2018 May; 23(3):570-577. PubMed ID: 29429890
[TBL] [Abstract][Full Text] [Related]
16. A comprehensive review of denosumab for bone metastasis in patients with solid tumors.
Gül G; Sendur MA; Aksoy S; Sever AR; Altundag K
Curr Med Res Opin; 2016; 32(1):133-45. PubMed ID: 26451465
[TBL] [Abstract][Full Text] [Related]
17. Is Treatment with Denosumab Associated with Local Recurrence in Patients with Giant Cell Tumor of Bone Treated with Curettage? A Systematic Review.
Tsukamoto S; Tanaka Y; Mavrogenis AF; Kido A; Kawaguchi M; Errani C
Clin Orthop Relat Res; 2020 May; 478(5):1076-1085. PubMed ID: 31794487
[TBL] [Abstract][Full Text] [Related]
18. Denosumab and Sunitinib in the treatment of giant-cell tumor of bone with pulmonary and bone metastases in an adolescent: A case report.
Wang G; Jiang S; Li Z; Dong Y
Medicine (Baltimore); 2019 Nov; 98(46):e17778. PubMed ID: 31725619
[TBL] [Abstract][Full Text] [Related]
19. Bisphosphonates or RANK-ligand-inhibitors for men with prostate cancer and bone metastases: a network meta-analysis.
Jakob T; Tesfamariam YM; Macherey S; Kuhr K; Adams A; Monsef I; Heidenreich A; Skoetz N
Cochrane Database Syst Rev; 2020 Dec; 12(12):CD013020. PubMed ID: 33270906
[TBL] [Abstract][Full Text] [Related]
20. "Primary" aggressive chondroblastoma of the humerus: a case report.
Harish K; Janaki MG; Alva NK
BMC Musculoskelet Disord; 2004 Mar; 5():9. PubMed ID: 15113430
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]